Literature DB >> 7540726

Antigen presentation mediated by recycling of surface HLA-DR molecules.

V Pinet1, M Vergelli, R Martin, O Bakke, E O Long.   

Abstract

Class II histocompatibility molecules associate with peptides derived from antigens that are processed in endocytic compartments. Antigen presentation to class II-restricted T cells generally requires newly synthesized class II molecules, associated invariant chain, and HLA-DM. Exceptions to these rules have been reported, but without description of an underlying mechanism. Here we show that presentation of immunodominant epitopes in the haemagglutinin protein of influenza virus and in myelin basic protein correlates with recycling of surface HLA-DR molecules. Truncation of either one of the alpha or beta cytoplasmic tails virtually eliminated internalization of HLA-DR molecules and presentation of haemagglutinin from inactive virus particles. In contrast, the invariant chain-dependent presentation of matrix antigen from the same virus particles was unaffected by these truncations. Thus HLA-DR cytoplasmic tails are not required for the conventional presentation pathway, but jointly contribute a signal for an alternative pathway involving internalization of HLA-DR molecules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540726     DOI: 10.1038/375603a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  70 in total

Review 1.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.

Authors:  G Moldenhauer; C Henne; J Karhausen; P Möller
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

3.  Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells.

Authors:  S N Karagiannis; J K Warrack; K H Jennings; P R Murdock; G Christie; K Moulder; B J Sutton; H J Gould
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 4.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

5.  Intracellular trafficking pathway of newly synthesized CD1b molecules.

Authors:  V Briken; R M Jackman; S Dasgupta; S Hoening; S A Porcelli
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

6.  Novel approach to probe subunit-specific contributions to N-methyl-D-aspartate (NMDA) receptor trafficking reveals a dominant role for NR2B in receptor recycling.

Authors:  Tina Tze-Tsang Tang; John D Badger; Paul A Roche; Katherine W Roche
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

7.  Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.

Authors:  G Girolomoni; M T Valle; V Zacchi; M G Costa; A Giannetti; F Manca
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 8.  The elucidation of non-classical MHC class II antigen processing through the study of viral antigens.

Authors:  Asha Purnima Veerappan Ganesan; Laurence C Eisenlohr
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

9.  Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells.

Authors:  Timothy E Quan; Robert M Roman; Benjamin J Rudenga; V Michael Holers; Joseph E Craft
Journal:  Arthritis Rheum       Date:  2010-06

10.  Reactivation by exon shuffling of a conserved HLA-DR3-like pseudogene segment in a New World primate species.

Authors:  Gaby G M Doxiadis; Marit K H van der Wiel; Herbert P M Brok; Natasja G de Groot; Nel Otting; Bert A 't Hart; Jon J van Rood; Ronald E Bontrop
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.